-
1 Comment
The Pennant Group, Inc is currently in a long term downtrend where the price is trading 10.7% below its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.6.
The Pennant Group, Inc's total revenue rose by 20.6% to $108M since the same quarter in the previous year.
Its net income has increased by 205.8% to $4M since the same quarter in the previous year.
Finally, its free cash flow grew by 38.9% to $-3M since the same quarter in the previous year.
Based on the above factors, The Pennant Group, Inc gets an overall score of 4/5.
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US70805E1091 |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | 880M |
|---|---|
| PE Ratio | 36.51 |
| Target Price | 31.25 |
| Beta | 1.73 |
| Dividend Yield | None |
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities in Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for PNTG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
